456 Studies Now Enrolling
Mechanistic registry to examine whether the corona virus disease 2019 (COVID-19) accelerates atherosclerotic plaque progression.
COVID CT Registry (Healthy Volunteers)
| Sponsor: | National Institute of Health |
| Enrolling: | Male and Female Patients |
| Study Length: | 3 Years |
| Clinic Visits: | 1 |
| IRB Number: | AAAT9812 |
| Contact: | Michelle Castillo: 732-277-7644 / mc5067@cumc.columbia.edu |
Additional Study Information:
*Non-COVID* We are seeking patients that have had a pre-COVID heart CT scan (Coronary Computed Tomography Angiography) that was performed at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital before March of 2020. For this study, half of patients will be required to have had COVID-19 symptoms (e.g., fever, cough, shortness of breath) and would have tested positive for COVID-19 (by an FDA-approved test). The other half will not have had a prior diagnosis of COVID-19. If you enroll in the study, you will be given a CT, asked to provide a blood sample as well as answer the study questionnaires, and get an ECG done. The total duration of the tests is 3 hours. It can be done in 1 or 2 study visits, whichever works best for your schedule. You will be compensated $100 after all tests are completed.
